Pad Chivukula is COO & CSO at Arcturus Therapeutics Holdings Inc. (ARCT). They have made 16 open-market trades across 1 company since 2020, most recently 2024-10-15.
CIK 0001727317
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARCT | 435,334 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2024-10-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARCT | SELL · 10b5-1 | 2024-10-15 | 2024-10-16 | $20.76 | $498K | -4.2% | -21.6% | -18.8% |
| ARCT | SELL · 10b5-1 | 2024-06-05 | 2024-06-07 | $45.00 | $5K | -15.7% | -31.6% | -40.3% |
| ARCT | SELL · 10b5-1 | 2024-06-03 | 2024-06-04 | $40.01 | $1.0M | -25.2% | -48.2% | -53.2% |
| ARCT | SELL · 10b5-1 | 2024-03-25 | 2024-03-27 | $35.02 | $1.2M | -4.2% | -19.6% | -20.5% |
| ARCT | SELL · 10b5-1 | 2024-03-19 | 2024-03-21 | $35.01 | $600K | -0.9% | -18.1% | -19.5% |
| ARCT | SELL · 10b5-1 | 2023-11-01 | 2023-11-03 | $18.72 | $94K | +15.0% | +22.5% | +77.0% |
| ARCT | SELL · 10b5-1 | 2023-10-02 | 2023-10-04 | $25.61 | $128K | -9.6% | -21.9% | +32.0% |
| ARCT | SELL · 10b5-1 | 2023-09-01 | 2023-09-05 | $31.45 | $157K | -8.0% | -18.1% | -22.6% |
| ARCT | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $34.91 | $349K | -9.0% | -5.7% | -43.0% |
| ARCT | SELL · 10b5-1 | 2023-07-14 | 2023-07-18 | $35.01 | $875K | -8.4% | -25.3% | -39.6% |
| ARCT | SELL · 10b5-1 | 2023-07-03 | 2023-07-07 | $28.75 | $144K | +21.1% | +8.6% | -13.3% |
| ARCT | SELL · 10b5-1 | 2023-06-01 | 2023-06-05 | $27.16 | $136K | +2.4% | +5.6% | +15.7% |
| ARCT | SELL · 10b5-1 | 2023-05-10 | 2023-05-12 | $30.08 | $752K | -7.9% | -10.6% | -4.4% |
| ARCT | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $25.93 | $130K | +16.7% | +2.4% | +33.0% |
| ARCT | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $25.38 | $127K | +6.5% | +3.5% | +8.3% |
| ARCT | SELL | 2023-03-06 | 2023-03-08 | $16.07 | $80K | -6.0% | +52.7% | +63.8% |
| ARCT | SELL | 2022-01-04 | 2022-01-06 | $40.00 | $324K | -24.0% | -29.2% | -14.8% |
| ARCT | SELL | 2021-12-16 | 2021-12-20 | $40.00 | $145K | -22.1% | -43.9% | -48.5% |
| ARCT | SELL | 2021-12-08 | 2021-12-10 | $40.00 | $255K | +23.3% | -1.1% | -43.5% |
| ARCT | SELL | 2021-11-01 | 2021-11-03 | $44.41 | $888K | -21.4% | -18.2% | -41.3% |
| ARCT | SELL | 2021-10-01 | 2021-10-04 | $44.36 | $444K | +14.3% | +10.9% | -3.7% |
| ARCT | SELL | 2021-09-01 | 2021-09-02 | $55.86 | $559K | -7.5% | -27.4% | -33.7% |
| ARCT | SELL | 2021-08-03 | 2021-08-05 | $40.07 | $401K | -5.1% | +8.1% | -12.8% |
| ARCT | SELL | 2021-04-01 | 2021-04-05 | $42.95 | $430K | -5.4% | -23.1% | -18.1% |
| ARCT | SELL | 2021-03-01 | 2021-03-03 | $54.23 | $542K | +4.7% | -15.5% | -39.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.